News Archive

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2015 Archives

Dec 17, 2015
Dec 15, 2015
--NDA includes comprehensive package of bioequivalence and abuse-deterrent data--
Dec 14, 2015
Dec 9, 2015
Dec 3, 2015
--Egalet regains worldwide rights to Phase 1 abuse-deterrent, extended-release hydrocodone, S-718632--
Dec 2, 2015
Nov 16, 2015
Nov 12, 2015
Nov 4, 2015
--Company began commercializing OXAYDO™ and closed $86.3 million equity financing--
Oct 28, 2015
Oct 21, 2015
Oct 5, 2015
Sep 29, 2015
--Strong abuse-deterrent data supports potential for ARYMO®, an abuse-deterrent, extended-release morphine formerly known as Egalet-001, with NDA expected to be submitted in fourth quarter--
Sep 15, 2015
--Company to provide update on commercial launch of SPRIX® Nasal Spray and OXAYDO™ and pipeline products, including abuse-deterrent, extended-release morphine, Egalet-001--
Sep 10, 2015
--Additional data demonstrate strong abuse-deterrent profiles of Egalet's abuse-deterrent, extended-release morphine, Egalet-001, and abuse-deterrent, extended-release oxycodone, Egalet-002--
Sep 9, 2015
Sep 1, 2015
--Data demonstrate efficacy of SPRIX® Nasal Spray for acute pain compared to combination opioid products and strong abuse-deterrent profile of Egalet-001 and Egalet-002--
Aug 6, 2015
--Company deployed specialty sales force, began promoting SPRIX® Nasal Spray, prepared to launch OXAYDO™ in third quarter and completed abuse-deterrent and bioequivalence studies of Guardian™ Technology product candidate Egalet-001, which will support fourth quarter new drug application (NDA) submission --
Jul 31, 2015
Jul 28, 2015
Jul 27, 2015
Jul 23, 2015
Jul 1, 2015
Jun 30, 2015
--Hardness of Egalet-002 tablet precluded chewing as method of manipulation requiring a greater level of effort--
Jun 29, 2015
-- Egalet-001 met primary endpoint of reduced drug liking compared to MS Contin® with drug liking scores similar to placebo --
 

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.